Ketut Suryana

Dr. Ketut Suryana

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in HIV/AIDS - Research and Palliative Care
Verified
Journal Article
Open access
PDF file
KSKetut Suryana
Ketut Suryana
HSHamong Suharsono
Hamong Suharsono
IAI Gede Putu Jarwa Antara
I Gede Putu Jarwa Antara
Background: Oral candidiasis (OC) is the most frequent opportunistic infection of the oral cavity caused by Candida species overgrowth. A wide variety of risk factor that contributes to yeast infection especially candidiasis. It might be acting as an early marker for people living with HIV/AIDS (PLWHA). There are some risk factors for PLWHA associated OC at Wangaya hospital in Denpasar, Bali, Indonesia. Aim: To identify risk factors of OC in PLWHA at Wangaya Hospital in Denpasar, Bali, Indonesia. Settings and Design: Case control study was conducted from March 1, 2016 and July 30, 2019, included 448 participants (207 cases and 241 controls). Consecutive recruitment was employed. Methods: Cases were PLWHA (18 to 60 years old) with OC and controls without OC. Diagnosis of OC based on the clinical features which are the pseudomembranous candidiasis; oral thrush. An interviewer administered a structured questionnaire used to collect information on risk factors. Statistical analysis used: bivariate analysis was performed on all variables. Chi-square test with statistically significant was at a level of 0.05. Results: The participants included 207 (46.20%) PLWHA with OC and 241 (53.80%) PLWHA who did not have OC. The majority participants, 293 (65.40%) were male. OC was associated with age [p = 0.03; OR = 0.66 (95% CI:0.45– 0.95)]; sex [p = 0.002; OR = 1.88 (95% CI:1.26– 2.80)]; Xerostomia [p = 0.000; OR = 4.15 (95% CI:2.76– 6.23)]; smoking [p = 0.000; OR = 6.83 (95% CI: 4.46– 10.44)]; alcohol consumption [p = 0.000; OR = 5.76 (95% CI: 3.74– 8.83)]; antibiotic usage [p = 0.000; OR = 4.49 (95% CI: 2.93– 6.90)]; CD4 count [p = 0.000; OR = 3.29 (95% CI:2.24– 4.86)]; HIV clinical stage [p = 0.000; OR = 3.58 (95% CI 2.39– 5.37)]. No significant association between prothesis with OC. Conclusion: We found that age, sex, xerostomia, smoking, alcohol consumption, antibiotic usage, CD4 counts and advanced HIV Clinical stage (AIDS) were significant associated risk factors for OC in PLWHA.

1 November 2019 in HIV/AIDS - Research and Palliative Care
Verified
Journal Article
Open access
PDF file
KSKetut Suryana
Ketut Suryana
HSHamong Suharsono
Hamong Suharsono
IAI Gede Putu Jarwa Antara
I Gede Putu Jarwa Antara
Background: Acquired Immunodeficiency Syndrome (AIDS) is a major public health problem. Recently AIDS was considered as a manageable chronic disease. High adherence to Anti-Retroviral Therapy (ART) is necessary to achieve undetectable viral load, reduce morbidity, mortality and to improve the quality of life. It is also preventing the drug resistance, reducing the transmission and finally leading to live longer and healthier. Objectives: To assess the factor associated with ART adherence among people living with HIV/AIDS (PLWHA) at Wangaya Hospital, in Denpasar, Bali, Indonesia. Methodology: A cross-sectional study was carried out during January 2015–December 2017 among 202 PLWHA taking ART for at least 6 months. The participants were interviewed using a semi-structured questionnaire to obtain data on socio-demographic characteristics. The data were analyzed using SPSS software for windows version 24.0. Chi-square test was done, the precision value of 95% (p<0.05) was considered statistically to be significant. Results: A total of 202 PLWHA taking ART, 170 (84.16%) were reported with high adherence (≥95%), 32 (15.84%) were low adherence (<95%). Factors found to be independently associated with high adherence to ART were employment status/occupation (p = 0.011), type of ARV (due to adverse effect of ART) (p = 0.002) and family support (p < 0.001). Conclusion: This study found that the factor associated with ART adherence among PLWHA who visited Wangaya Hospital, in Denpasar, Bali, Indonesia, was employment status, type of ARV and family support.

15 September 2022 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
KSKetut Suryana
Ketut Suryana
NDNi Wayan Wina Dharmesti
Ni Wayan Wina Dharmesti
IRIb Ngurah Rai
Ib Ngurah Rai
Introduction: Patients with delayed intensive phase sputum conversion have a higher risk of multidrug resistant-tuberculosis (MDR-TB) and poorer treatment outcomes. Both, host (immune response and comorbidity) and pathogen factors play important roles in determining sputum conversion after treatment initiation. Impaired host immune response, especially the cellular components, as defined by the increased pre-treatment level of neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR) and other additional factors, were associated with severe active TB. Purpose: To evaluate whether impaired immune responses (high pre-treatment level of NLR and MLR) and other factors associate with delayed sputum conversion at the end of the intensive phase treatment. Patients and Methods: This was a case–control study from 2016 to 2020, which retrospectively analyzed the pre-treatment level of NLR, MLR and other factors among patients with new cases of pulmonary tuberculosis (PTB). Results: A total of 62 patients (31 cases and 31 control). The cut-off value of high pretreatment level of NLR and MLR was 5.065 and 0.585, respectively. Bivariate analysis showed that pretreatment NLR ≥ 5.065 (OR 8.23, CI 95% 2.48– 27.32, p < 0.001), MLR ≥ 0.585 (OR 10.18, 95% CI 3.13– 33.18, p < 0.001) and BMI < 18.5 (OR 2.91, 95% CI 1.03– 8.20, p = 0.041) were associated with an increased risk of delayed sputum conversion. Multivariate analysis, however, showed that pretreatment NLR ≥ 5.065 was not significantly associated with delayed sputum conversion (AOR 3.370, 95% CI 0.71– 15.91, p value 0.125). A high pretreatment of MLR (AOR 30.802, 95% CI 3.22– 287.55, p value 0.003) and lower BMI (AOR 10.942, 95% CI 1.121– 98.563, p value 0.033) were significantly associated with an increased risk of delayed intensive phase sputum conversion. Conclusion: High MLR pretreatment and a low BMI were significantly associated with an increased risk of delayed sputum conversion at the end of the PTB intensive phase treatment. High NLR pretreatment, smoking, diabetes, and HIV were not associated with sputum conversion.

14 September 2022 in Frontiers in Psychiatry
Verified
Journal Article
Open access
KSKetut Suryana
Ketut Suryana
HSHamong Suharsono
Hamong Suharsono
AIAgung Wiwiek Indrayani
Agung Wiwiek Indrayani
LALuh Nyoman Arya Wisma Ariani
Luh Nyoman Arya Wisma Ariani
WPWayan Wahyu Semara Putra
Wayan Wahyu Semara Putra
NYNi Made Dwita Yaniswari
Ni Made Dwita Yaniswari
Background: The coronavirus disease (COVID-19) pandemic causes fear and anxiety symptoms on some vulnerable populations such as patients living with human immunodeficiency virus (HIV) (PLWH). Physical distancing (during consultation in the clinic) and isolation restrictions will likely have a negative impact on/disruption to all care continuum services of HIV diseases although healthcare services and access to anti-retroviral therapy (ART) have continued to operate.Objective: To investigate the factors associated with ART adherence among PLWH during the COVID-19 pandemic.Methodology: A cross-sectional study was conducted on 324 PLWH who had been on ART for at least 6 months between June 2020 and January 2021. A semi-structured questionnaire was used to interview participants to collect data on sociodemographic characteristics and other factors.Results: Of 324 PLWH taking ART, 264 (81.48%) had high adherence (≥95%) and 60 (18.52%) had low adherence (< 95%). Factors independently associated with high ART adherence were employment status (adjusted odds ratio (AOR): 0.030, 95% confidence interval (CI): 0.010–0.088; p < 0.001), type of antiretroviral (ARV) (AOR: 3.101, 95% CI: 1.137–8.456; p = 0.027), family support (AOR: 0.157, 95% CI: 0.052–0.475; p = 0.001), the perception that the COVID-19 pandemic negatively impacts the ability to attend clinics (AOR: 7.339, 95% CI: 1.46–36.79; p = 0.015), and the perception that the COVID-19 pandemic negatively impacts the ability to take ART (AOR: 10.611, 95% CI: 2.98–37.72; p < 0.001).Conclusions: During the COVID-19 pandemic, factors associated with high ART adherence among PLWH attending the Hospital of Wangaya in Denpasar, Bali, Indonesia were employment status, ART type [non-fixed dose combination (FDC)], family support, and the perception that the COVID-19 pandemic negatively impacts the ability to attend clinics and to take ART.

18 June 2021 in The Open AIDS Journal
Verified
Journal Article
Open access
PDF file
KSKetut Suryana
Ketut Suryana
Background: World Health Organization (WHO) (2015) recommended that all people diagnosed with human immunodeficiency virus (HIV)-positive initiate Highly Active Anti Retroviral Therapy (HAART) immediately (less than a week), irrespective of CD4 count (Universal Test and Treat / UTT) Program. Objective: To evaluate the impact of UTT as a current therapeutic program on HIV treatment outcomes, coverage, adherence, and lost to follow-up (LTFU) at Wangaya Hospital in Denpasar, Bali, Indonesia. Methods: A Retrospective cohort study was conducted during July 2017 - June 2018 (Pre-UTT) and September 2018 – August 2019 (Post-UTT). Around 402 medical records were selected, reviewed, and enrolled. Data were analyzed using SPSS software for windows version 24.0. Bivariate analysis (Chi-square test) was performed on all variables with a statistically significant t level of 0.05. Results: Among 4,322 new visitors; 3,585 (82.95%) agreed to take HIV test and 402(11.21%) were confirmed HIV reactive. Most participants confirmed HIV reactive occured at age 25-34 years old and 230 (57.21%) were male. The majority education level were primary (Junior high school) 302(75.12%), 379(94.28%) were employed and 281 (69.90%) stayed in Denpasar. About 350 (87.06%) received HAART, 298 (85.14%) with high adherence and 52 (14.86%) LTFU. Pre-UTT, HAART coverage; 83.03% (181), were statistically significant increased to 91.85% (169) post UTT (p=0.000). High adherence pre-UTT; 79.56% (144) was significantly increased to 91.12% (154) post UTT (p=0.006) and LTFU were significantly decreased; 20.44% (37) to 8.87% (15) (p=0.006). Conclusion: UTT program significantly improve the HIV treatment outcome (increased coverage, adherence, and decreased LTFU).

1 May 2019 in HIV/AIDS - Research and Palliative Care
Verified
Journal Article
Open access
PDF file
ISI Ketut Agus Somia
I Ketut Agus Somia
TMTuti Parwati Merati
Tuti Parwati Merati
IBI Made Bakta
I Made Bakta
IMIda Bagus Putra Manuaba
Ida Bagus Putra Manuaba
WYWayan Putu Sutirta Yasa
Wayan Putu Sutirta Yasa
RWRudi Wisaksana
Rudi Wisaksana
Purpose: This study aimed to determine whether high levels of serum IL-6 and serum hepcidin and CD46 months, had >95% adherence of cARV within 6 months, did not have any clinical failure, did not have any immunological failure and did not receive switch therapy within 6 months. Chi-square test and logistic regression analysis were performed. Results: A total of 42 cases and 42 controls were included in this study. Significant differences were found between case and control, which included serum IL-6, serum hepcidin, smoking, creatinine clearance, anemia at the initiation of cARV, CD4 at the initiation of cARV and actual CD4 (cell/μL). High levels of serum IL-6, high levels of serum hepcidin and CD4< 350 cells/μl were risk factors for ACD. After adjusted with anemia at cARV initiation and BMI, we found that high levels of serum IL-6 (adjusted OR: 17.682; 95% CI: 3.442–90.826), high levels of serum hepcidin (adjusted OR: 10.562; 95% CI: 2.531–44.076) and CD4 <350 cells/μl (adjusted OR: 4.181; 95% CI: 5.6–12.381) remain as risk factors for ACD. Conclusion: High levels of serum IL-6, high levels of serum hepcidin and CD4 count <350 cells/μL were risk factors for ACD in HIV patients with cARV therapy.